CPT code 15156 represents the incremental reporting unit for placement of a tissue cultured epidermal autograft to complex anatomical sites (face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and multiple digits). It is used for each additional 1 cm2 of grafted skin beyond the initial 25 cm2, up to 75 cm2. This code matters nationally because tissue-engineered skin grafting is a specialized surgical service with implications for coding accuracy, coverage policy, and cost management across payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a succinct overview of clinical context for the procedure, the typical sites of service where the procedure is delivered, and operational considerations for reporting incremental graft area. The publication outlines benchmarking anchors, common modifiers observed in claims, and areas where policy language commonly affects coverage and prior authorization requirements. It also highlights documentation elements typically required to support use of this incremental unit-based code.

Data not available in the input for some elements (such as associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific fee benchmarks) is noted where applicable. The content is intended for national audiences including coding professionals, revenue integrity teams, and policy analysts seeking a concise reference to CPT code 15156.